Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1965
website : http://www.wibp.com.cn/
Main Product : Vaccines, blood products, diagnostic reagents
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a renowned biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Established in 1965, the company has grown to become a leading player in the industry, serving both domestic and international markets with high-quality products. With a large company size and a strong competitive position, Wuhan Institute of Biological Products Co., Ltd. continues to innovate and expand its product portfolio to meet the growing demand for healthcare solutions worldwide.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 2003
website : www.tianyuanbio.com
Main Product : Recombinant human insulin, insulin analogs, and other peptide products
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of insulin and peptide products. Established in 2003, the company has grown to become a key player in the pharmaceutical industry, serving both domestic and international markets with high-quality products.
Jiangsu Province Centers for Disease Control and Prevention
Establishment time : 1952
website : http://www.jscdc.cn/
Main Product : Disease prevention and control services, public health research
Company Profile
Jiangsu Province Centers for Disease Control and Prevention is a government agency dedicated to promoting public health and preventing the spread of infectious diseases in Jiangsu Province. With a history dating back to 1952, the center offers a range of services including disease surveillance, outbreak response, vaccination programs, and health education initiatives. As a key player in the public health sector, the Jiangsu CDC plays a crucial role in safeguarding the health and well-being of the local population.
Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : http://www.cibp.com.cn/
Main Product : Vaccines, blood products, diagnostic reagents
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a renowned company specializing in the production of vaccines, blood products, and diagnostic reagents. Established in 1958, the company has grown to become a key player in the industry with a large market presence both domestically and internationally. With a focus on research and development, the company continues to innovate and provide high-quality products to meet the needs of customers worldwide.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2008
website : www.chengdabio.com
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. was founded in 2008 and specializes in the production of probiotics, enzymes, and feed additives. With a medium-sized company size, Chengda Biotechnology serves markets in China, Southeast Asia, and the Middle East. Despite strong competition in the industry, the company has established a reputation for quality and innovation. Visit their website at www.chengdabio.com for more information.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1969
website : www.cdibp.com.cn
Main Product : vaccines, blood products, and diagnostic reagents
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a state-owned enterprise specializing in the research, development, and production of biological products. With a history of over 50 years, the company has established itself as a trusted provider of vaccines, blood products, and diagnostic reagents in both domestic and international markets.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : 1992
website : www.btbp.com.cn
Main Product : vaccines, blood products, and diagnostic reagents
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. Established in 1992, the company has grown to become a key player in the healthcare industry, serving markets in China, Southeast Asia, the Middle East, and Africa. With a strong focus on quality and innovation, Beijing Tiantan Biological Products Co., Ltd. continues to strive for excellence in providing safe and effective healthcare solutions to customers worldwide.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2009 and has since become a leading provider of biotechnology products.
website :
Main Product : With a team of 100-500 employees, BCHT Bio is dedicated to providing high-quality products to customers worldwide.
Company Profile
With a strong reputation for quality and reliability, Changchun BCHT Biotechnology Co., Ltd. continues to be a trusted partner for researchers and scientists worldwide.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and has since become a prominent player in the biopharmaceutical industry.
website :
Main Product : With a workforce of 500-1000 employees, Shenzhen Kangtai Biological Products Co., Ltd. operates on a large scale to meet market demands.
Company Profile
Overall, Shenzhen Kangtai Biological Products Co., Ltd. is a reputable and reliable biopharmaceutical company dedicated to improving healthcare outcomes worldwide.
July 04, 2024
